Long-Term Effects of Campanyl in the Treatment of Patients with Recurrent Calcium Urinary Stones

  • Chapter
Urolithiasis

Abstract

The nonabsorbable cation exchange resin Campanyl (Figure 1) complexes with dietary calcium in the gastrointestinal tract and hinders its absorption. Campanyl is 50% amberlite, in the K+ form, and 46.8% sorbital. It binds 1.935 mEq Ca2+/(g resin). The drug was given orally with meals as a long-term therapy in patients with recurrent calcium urolithiasis1–4 After exclusion of primary hyperparathyroidism, an absorptive hypercalciuria could be detected in 40% and a resorptive, mixed (absorptive + resorptive) or renal hypercalciuria in 20% of the patients. The remaining patients were normocalciuric or inconstantly hypercalciuric.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook
EUR 9.99
Price includes VAT (Germany)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
EUR 106.99
Price includes VAT (Germany)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. E. W. Rugendorff, H.-J. Schneider, G. Gundlach, W. A. Behrendt, D. Kuhn, and D. Gundlach, Urologe A 16:197 (1977).

    CAS  Google Scholar 

  2. W. Rugendorff, H.-J. Schneider, D. Kuhn, W. A. Behrendt, and S. Kornmann, in: “Pathogenese und Klinik der Harnsteine V,” Dr. Dietrich Steinkopff Verlag, Darmstadt (1977).

    Google Scholar 

  3. H.-J. Schneider and G. Stein, Dt. Gesundh.-Wesen 34:2385 (1979).

    CAS  Google Scholar 

  4. O. Hallwachs, Urologe B 19:293 (1979).

    Google Scholar 

  5. C. Y. C. Pak, R. A. Kaplan, H. Bone, J. Townsend, and O. Waters, N. Engl. J. Med. 292:497 (1975).

    Article  PubMed  CAS  Google Scholar 

  6. E.W. Rugendorff, Medicamentum 6:234 (1967).

    Google Scholar 

  7. Th. Burghele, E. W. Rugendorff, and T. Covaliu, Urologe A 6:234 (1967).

    CAS  Google Scholar 

  8. Hallwachs, in: “Pathogenese und Klinik der Harnsteine VII,” Dr. Dietrich Steinkopff Verlag, Darmstadt (1979).

    Google Scholar 

  9. E.W. Rugendorff and S. Kornmann, in: “Pathogenese und Klinik der Harnsteine VI,” Dr. Dietrich Steinkopff Verlag, Darmstadt (1978).

    Google Scholar 

  10. E. Hering, R. Hautmann, and W. Lutzeyer, in: “Pathogenese und Klinik der Harnsteine VII,” Dr. Dietrich Steinkopff Verlag, Darmstadt (1979)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1981 Springer Science+Business Media New York

About this chapter

Cite this chapter

Rugendorff, E.W., Schneider, HJ., Hallwachs, O. (1981). Long-Term Effects of Campanyl in the Treatment of Patients with Recurrent Calcium Urinary Stones. In: Smith, L.H., Robertson, W.G., Finlayson, B. (eds) Urolithiasis. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-8977-4_46

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-8977-4_46

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-8979-8

  • Online ISBN: 978-1-4684-8977-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Navigation